Beijing Tiantan Biological Products Corp Ltd Total Liabilities

Latest as of September 2025: CN¥1.60 Billion CNY ≈ $234.69 Million USD

Beijing Tiantan Biological Products Corp Ltd total liabilities. Based on the latest financial reports, Beijing Tiantan Biological Products Corp Ltd (600161) has total liabilities worth CN¥1.60 Billion CNY (≈ $234.69 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 600161 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Beijing Tiantan Biological Products Corp Ltd (1995–2024)

Total liabilities of Beijing Tiantan Biological Products Corp Ltd from 1995 to 2024. This chart illustrates how Beijing Tiantan Biological Products Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 600161 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Beijing Tiantan Biological Products Corp Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing Tiantan Biological Products Corp Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Rubis SCA PA:RUI	France	€3.62 Billion
Century Aluminum Company NASDAQ:CENX	USA	$1.34 Billion
Apeloa Pharmaceutical Co Ltd SHE:000739	China	CN¥5.68 Billion
The a2 Milk Company Ltd AU:A2M	Australia	AU$887.30 Million
Covivio Hotels PA:COVH	France	€3.23 Billion
Tel Aviv Stock Exchange TA:TASE	Israel	ILA1.14 Billion
Georg Fischer AG SW:GF	Switzerland	CHF3.60 Billion
Companhia Energética de Minas Gerais MX:CIGN	Mexico	MX$38.45 Billion

Liability Composition Analysis (1995–2024)

This chart breaks down Beijing Tiantan Biological Products Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 600161 total asset value.

Liquidity & Leverage Metrics

Beijing Tiantan Biological Products Corp Ltd Total Liabilities Ratios Explained

Beijing Tiantan Biological Products Corp Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	6.01	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Tiantan Biological Products Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Tiantan Biological Products Corp Ltd (1995–2024)

The table below shows the annual total liabilities of Beijing Tiantan Biological Products Corp Ltd from 1995 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.34 Billion ≈ $195.55 Million	-6.79%
2023-12-31	CN¥1.43 Billion ≈ $209.79 Million	-9.51%
2022-12-31	CN¥1.58 Billion ≈ $231.84 Million	+20.87%
2021-12-31	CN¥1.31 Billion ≈ $191.81 Million	-13.20%
2020-12-31	CN¥1.51 Billion ≈ $220.97 Million	+32.81%
2019-12-31	CN¥1.14 Billion ≈ $166.39 Million	+57.88%
2018-12-31	CN¥720.19 Million ≈ $105.39 Million	+49.59%
2017-12-31	CN¥481.46 Million ≈ $70.45 Million	-85.59%
2016-12-31	CN¥3.34 Billion ≈ $489.08 Million	-1.57%
2015-12-31	CN¥3.40 Billion ≈ $496.90 Million	-10.59%
2014-12-31	CN¥3.80 Billion ≈ $555.74 Million	+9.82%
2013-12-31	CN¥3.46 Billion ≈ $506.05 Million	+14.17%
2012-12-31	CN¥3.03 Billion ≈ $443.22 Million	+70.36%
2011-12-31	CN¥1.78 Billion ≈ $260.16 Million	+36.14%
2010-12-31	CN¥1.31 Billion ≈ $191.10 Million	+7.76%
2009-12-31	CN¥1.21 Billion ≈ $177.34 Million	+175.83%
2008-12-31	CN¥439.35 Million ≈ $64.29 Million	+18.96%
2007-12-31	CN¥369.34 Million ≈ $54.05 Million	+3.69%
2006-12-31	CN¥356.20 Million ≈ $52.12 Million	+98.25%
2005-12-31	CN¥179.67 Million ≈ $26.29 Million	+42.93%
2004-12-31	CN¥125.70 Million ≈ $18.39 Million	-21.06%
2003-12-31	CN¥159.24 Million ≈ $23.30 Million	-26.18%
2002-12-31	CN¥215.73 Million ≈ $31.57 Million	+24.24%
2001-12-31	CN¥173.64 Million ≈ $25.41 Million	+4.12%
2000-12-31	CN¥166.77 Million ≈ $24.40 Million	+4.31%
1999-12-31	CN¥159.88 Million ≈ $23.40 Million	+42.06%
1998-12-31	CN¥112.54 Million ≈ $16.47 Million	+73.47%
1997-12-31	CN¥64.88 Million ≈ $9.49 Million	-11.20%
1996-12-31	CN¥73.06 Million ≈ $10.69 Million	+12.10%
1995-12-31	CN¥65.18 Million ≈ $9.54 Million	--

About Beijing Tiantan Biological Products Corp Ltd

SHG:600161 China Biotechnology

Market Cap

$3.62 Billion

CN¥24.74 Billion CNY

Market Cap Rank

#4257 Global

#611 in China

Share Price

CN¥12.51

Change (1 day)

-1.26%

52-Week Range

CN¥11.41 - CN¥18.64

All Time High

CN¥74.24